Your session is about to expire
← Back to Search
Mindfulness Based Walking Therapy (MBWT) for Parkinson's Disease (MMR34 Trial)
N/A
Waitlist Available
Led By Kerri Rawson, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
MMR34 Trial Summary
This trial will study if a mindfulness intervention can help people with Parkinson disease who have freezing of gait, a severe motor disturbance.
Eligible Conditions
- Parkinson's Disease
- Freezing of Gait
MMR34 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence: Number of Hours Participants Practice Mindfulness at Home
Attendance of Participants: Number of Participants at Each Session
Recruitment of Sample: Number of Participants Recruited
+1 moreMMR34 Trial Design
1Treatment groups
Experimental Treatment
Group I: Mindfulness Based Walking Therapy (MBWT)Experimental Treatment1 Intervention
Participants will participate in MBWT.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Walking Therapy (MBWT)
2022
N/A
~10
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,864 Total Patients Enrolled
Kerri Rawson, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
24 Total Patients Enrolled
Gammon Earhart, PT, PhDPrincipal InvestigatorWashington University School of Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the ceiling of participants for this trial?
"Affirmative. The clinicaltrials.gov database reveals that this trial, which was first published on March 4th 2022, is actively collecting applicants. A total of 24 subjects need to be enrolled from one specific medical facility."
Answered by AI
Is this clinical examination currently welcoming participants?
"According to clinicaltrials.gov, applications are now being accepted for this trial which was first introduced on March 4th 2022 and revised most recently on April 21st 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger